November 28, 2016 - By Dolores Ford
The director of Stryker Corp, Ronda Stryker a few days ago got almost $1,352,716 USD for 12,000 shares in the Stryker Corp firm at an approx. $112.7 per every share. She also sold 114,000 shares valued at $12,910,550 USD in the last month. At the moment, Ronda Stryker has rights to a total of 23.99 million shares or 6.39% of the company’s market cap (total dollar market value of all company’s outstanding shares). The original report was made public on November 28, 2016 with the U.S. Security & Exchange Commission and is now available for public review here.
Out of 19 analysts covering Stryker Corporation (NYSE:SYK), 11 rate it a “Buy”, 2 “Sell”, while 6 “Hold”. This means 58% are positive. $130 is the highest target while $88 is the lowest. The $109.83 average target is -2.82% below today’s ($113.02) stock price. Stryker Corporation has been the topic of 25 analyst reports since July 27, 2015 according to StockzIntelligence Inc. Suntrust Robinson initiated the stock with “Buy” rating in Friday, October 14 report. The firm has “Underperform” rating by BMO Capital Markets given on Monday, December 14. The stock has “Neutral” rating given by Goldman Sachs on Friday, November 13. The company was upgraded on Tuesday, November 1 by BMO Capital Markets. The stock of Stryker Corporation (NYSE:SYK) earned “Neutral” rating by Robert W. Baird on Wednesday, April 13. The firm has “Buy” rating given on Wednesday, April 27 by Sterne Agee CRT. The company was maintained on Friday, July 24 by RBC Capital Markets. Barclays Capital initiated Stryker Corporation (NYSE:SYK) on Monday, April 11 with “Underweight” rating. The stock of Stryker Corporation (NYSE:SYK) earned “Buy” rating by Guggenheim on Thursday, June 9. Stifel Nicolaus maintained Stryker Corporation (NYSE:SYK) on Wednesday, August 12 with “Buy” rating.
Insitutional Activity: The institutional sentiment decreased to 0.79 in Q2 2016. Its down 0.14, from 0.93 in 2016Q1. The ratio fall, as 41 funds sold all Stryker Corporation shares owned while 325 reduced positions. 61 funds bought stakes while 280 increased positions. They now own 279.01 million shares or 2.26% less from 285.46 million shares in 2016Q1.
Moreover, Woodmont Counsel Limited Liability Com has 0.18% invested in Stryker Corporation (NYSE:SYK) for 5,091 shares. Jefferies Group Incorporated Ltd Liability Co has 1,100 shares for 0% of their US portfolio. Ipswich Investment Comm has 3,092 shares for 0.18% of their US portfolio. Moreover, Baldwin Brothers Ma has 0.04% invested in Stryker Corporation (NYSE:SYK) for 1,815 shares. Becker Capital Management Incorporated, a Oregon-based fund reported 3,022 shares. The Michigan-based Comerica Retail Bank has invested 0.15% in Stryker Corporation (NYSE:SYK). Girard Prtn Limited owns 9,578 shares or 0.44% of their US portfolio. Tiemann Investment Ltd Liability last reported 0.19% of its portfolio in the stock. Blue Finance Capital has invested 0.67% of its portfolio in Stryker Corporation (NYSE:SYK). Woodstock Corp has invested 0.52% of its portfolio in Stryker Corporation (NYSE:SYK). Cibc Markets last reported 0.04% of its portfolio in the stock. Hyman Charles D accumulated 0.1% or 5,354 shares. Focused Wealth Mngmt Incorporated holds 0.07% or 1,312 shares in its portfolio. Noesis Cap Mangement Corporation, a Florida-based fund reported 62,835 shares. Cap, a California-based fund reported 700,451 shares.
Insider Transactions: Since May 31, 2016, the stock had 2 insider purchases, and 63 selling transactions for $85.15 million net activity. The insider Doliveux Roch bought 46 shares worth $5,308. 12,000 shares with value of $1.32M were sold by STRYKER RONDA E on Wednesday, October 26. 1,111 Stryker Corporation (NYSE:SYK) shares with value of $129,987 were sold by Becker Yin C. $747,754 worth of Stryker Corporation (NYSE:SYK) shares were sold by Datar Srikant. Owen Katherine Ann sold $808,960 worth of stock or 6,674 shares. Another trade for 9,945 shares valued at $1.10M was sold by Scannell Timothy J. COX HOWARD E JR had sold 9,448 shares worth $1.11M on Monday, August 1.
About 476,987 shares traded hands. Stryker Corporation (NYSE:SYK) has risen 3.06% since April 25, 2016 and is uptrending. It has underperformed by 2.95% the S&P500.
Stryker Corporation is a medical technology company. The company has a market cap of $42.73 billion. The Firm operates through three divisions: Orthopaedics, MedSurg, and Neurotechnology and Spine. It has a 25.77 P/E ratio. The Company’s Orthopaedics segment products consist of implants used in hip and knee joint replacements and trauma and surgeries.
According to Zacks Investment Research, “Stryker Corporation develops, manufactures, and markets specialty surgical and medical products, including orthopaedic implants, bone cement, trauma systems used in bone repair, powered surgical instruments, endoscopic systems, craniomaxillofacial fixation devices, specialty surgical equipment used in neurosurgery and patient care and handling equipment for the global market and provide outpatient physical and occupational rehabilitation services.”
Analysts await Stryker Corporation (NYSE:SYK) to report earnings on January, 24. They expect $1.76 earnings per share, up 12.82% or $0.20 from last year’s $1.56 per share. SYK’s profit will be $665.41 million for 16.05 P/E if the $1.76 EPS becomes a reality. After $1.39 actual earnings per share reported by Stryker Corporation for the previous quarter, Wall Street now forecasts 26.62% EPS growth.
Stryker Corporation (Stryker), incorporated on February 20, 1946, is a medical technology company. The Firm operates through three divisions: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Firm offers its products to doctors, hospitals and other healthcare facilities. The Company’s products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment, and neurosurgical, neurovascular and spinal devices, as well as other medical device products used in a range of medical specialties. The Company’s products are sold in approximately 100 countries through the Company-owned sales subsidiaries and branches, as well as third-party dealers and distributors. The Firm offers a 1588 advanced imaging modalities (AIM) platform, which is designed for optimum visualization across surgical specialties.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Dolores Ford